Marko Monika, Pawliczak Rafał
Department of Immunopathology, Faculty of Biomedical Sciences and Postgraduate Training, Medical University of Lodz, Lodz, Poland.
Postepy Dermatol Alergol. 2018 Dec;35(6):563-571. doi: 10.5114/ada.2018.77607. Epub 2018 Nov 8.
Asthma and obesity are currently one of the most common diseases. Observing an increase in morbidity of obesity and asthma, it can be concluded that there is a link between these diseases. But the mechanism of this relation is not well known. Due to reduced movement in patients and treatment, asthma is conducive to obesity, and obesity can exacerbate the symptoms associated with asthma. Obesity can affect bronchial hyperresponsiveness. Increasing body fat in obese people leads to systemic inflammation and elevated serum levels of many proinflammatory cytokines (e.g. leptin) and anti-inflammatory ones (e.g. adiponectin) that can have a causal relationship to bronchial asthma, but human studies are ambiguous. Obese asthmatics are characterized by a phenotype: heavier asthma, worse response to treatment and control of asthma. It has been found that in obese people, weight loss reduces the severity of asthma symptoms, so in these patients, treatment should include weight control.
哮喘和肥胖是目前最常见的疾病之一。观察到肥胖症和哮喘的发病率有所上升,可以得出结论,这些疾病之间存在联系。但这种关系的机制尚不清楚。由于患者活动减少和接受治疗,哮喘会导致肥胖,而肥胖会加重与哮喘相关的症状。肥胖会影响支气管高反应性。肥胖人群体内脂肪增加会导致全身炎症,许多促炎细胞因子(如瘦素)和抗炎细胞因子(如脂联素)的血清水平升高,这可能与支气管哮喘存在因果关系,但人体研究结果并不明确。肥胖哮喘患者具有一种表型特征:哮喘更严重,对治疗和哮喘控制的反应更差。研究发现,肥胖人群体重减轻会降低哮喘症状的严重程度,因此对于这些患者,治疗应包括体重控制。